摘要
As one of the most promising tools for deep analyses of tumor characteristics, single-cell RNA sequencing(sc RNAseq) is well welcomed for the great advantages of analyzing tumor features at single cell levels(1). However, the substantial gap between clinical practice and basis research on sc RNA-seq still could not be ignored.